Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression (Q46624062)

23 December 2017

title

Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression (English)

1 reference

23 December 2017

1 reference

1 reference

Sho-Ichi Yamagishi

1

1 reference

23 December 2017

Masayoshi Takeuchi

2

1 reference

23 December 2017

Takanori Matsui

3

1 reference

23 December 2017

Kazuo Nakamura

4

1 reference

23 December 2017

Tsutomu Imaizumi

5

1 reference

23 December 2017

Hiroyoshi Inoue

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

23 December 2017

published in

FEBS Letters

1 reference

23 December 2017

volume

579

1 reference

23 December 2017

issue

20

1 reference

23 December 2017

page(s)

4265-4270

1 reference

23 December 2017

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

ARBs and target organ protection. Exploring benefits beyond their antihypertensive effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Atherosclerosis and diabetes: the RAGE connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Atherogenesis and advanced glycation: promotion, progression, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Advanced glycation end products (AGEs) and diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Oxidation-sensitive transcription factors and molecular mechanisms in the arterial wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.06.058

10.1016/J.FEBSLET.2005.06.058

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

16051229

1 reference

23 December 2017